LFGSX
Price
$31.86
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
RGEBX
Price
$74.40
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
Ad is loading...

LFGSX vs RGEBX

Header iconLFGSX vs RGEBX Comparison
Open Charts LFGSX vs RGEBXBanner chart's image
Lord Abbett Focused Growth R4
Price$31.86
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$74.40
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LFGSX vs RGEBX Comparison Chart
Loading...
VS
LFGSX vs. RGEBX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFGSX is a Sell and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 291B vs. LFGSX (64.9M). RGEBX pays higher dividends than LFGSX: RGEBX (0.16) vs LFGSX (0.00). LFGSX was incepted earlier than RGEBX: LFGSX (6 years) vs RGEBX (10 years). LFGSX is a more actively managed with annual turnover of: 169.00 vs. RGEBX (31.00). LFGSX has a lower initial minimum investment than RGEBX: LFGSX (0) vs RGEBX (250). LFGSX annual gain was more profitable for investors over the last year : 45.95 vs. RGEBX (28.39). LFGSX return over 5 years is better than : 101.52 vs. RGEBX (48.56).
LFGSXRGEBXLFGSX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years10 years-
Gain YTD32.09022.248144%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets64.9M291B0%
Annual Yield % from dividends0.000.16-
Returns for 1 year45.9528.39162%
Returns for 3 years-15.54-8.65180%
Returns for 5 years101.5248.56209%
Returns for 10 yearsN/A60.89-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANTX1.08N/A
N/A
AN2 Therapeutics
ZURA4.38N/A
N/A
Zura Bio Limited
CLMT21.02-0.10
-0.47%
Calumet Inc.
ACGL95.00-1.02
-1.06%
Arch Capital Group Ltd
ADMA19.11-0.26
-1.34%
ADMA Biologics